@LindaGailBekker Indeed,we benefited. And we were grateful at the time. However - still denying HCW options,that have become available to the public,is not beneficial. So what could be the motivation here? Whatever it is it is certainly no longer for the benefit of the HCW.
@pessimist_pat@miamalan@HealthZA@LindaGailBekker Not the case. HCW still do not have access through the normal channels. Still locked in the trial even if they had declined the second JnJ. That means 250000 HCW had 1 JnJ only, with no access to anything else, despite the evidence that another JnJ was inferior